Reaction
Lip Injury reporting signals
As of the last recalculation, Lip Injury appears in 1,292 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is EMICIZUMAB (PRR 41.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Emicizumab | 31 | 41.4 | 41.5 |
| Brivaracetam | 15 | 27.2 | 27.2 |
| Cladribine | 9 | 15.2 | 15.2 |
| Budesonide And Formoterol Fumarate Dihydrate | 84 | 14.8 | 14.9 |
| Cenobamate | 7 | 13.6 | 13.6 |
| Primidone | 8 | 12.7 | 12.7 |
| Glycerin, Lidocaine | 9 | 10.4 | 10.4 |
| Lacosamide | 23 | 10.1 | 10.1 |
| Tiotropium Bromide Inhalation Spray | 7 | 10.1 | 10.1 |
| Docosanol | 9 | 10.0 | 10.0 |
| Lanreotide Acetate | 4 | 8.2 | 8.2 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 7.5 | 7.5 |
| Budesonide, Glycopyrrolate, And Formoterol Fumarate | 3 | 4.6 | 4.6 |
| Pimavanserin Tartrate | 9 | 2.6 | 2.6 |
| Valbenazine | 3 | 1.9 | 1.9 |